ABOUT: Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include […]
INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today are Carlos Moreira the CEO for WISekey International Holding Limited the company trades […]
Myron Holubiak, CEO of Citius Pharmaceuticals took time to update WSA’s listeners on the companies’ progress since their previous interview. Mr. Holubiak provided an overview of the progress on the CTXR’s main products Mino-Lok and Mino-Wrap and shared how they are adapting the product to deal with COVID compliance and restrictions. He also talked about other programs in early stage development and went over key factors that make Citius a unique investment opportunity. Have a look below: […]
Interview with Myron Holubiak, CEO and President […]
Interview with Dwight Egan, CEO […]
Generex Biotechnology Corp. (OTCQB:GNBT) is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that […]
About: NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals. NaturalShrimp systems are self-contained, saltwater production […]
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]
One of the best features in our products is that we can predict how the system is going to perform through the weather. […]
Citius Pharmaceuticals (NASDAQ: CTXR) CEO: Myron Holubiak About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com